IL-2/NN
gene/NN
expression/NN
and/CC
NF-kappa/NN
B/NN
activation/NN
through/IN
CD28/NN
requires/VBZ
reactive/JJ
oxygen/NN
production/NN
by/IN
5-lipoxygenase/NN
./.

Activation/NN
of/IN
the/DT
CD28/NN
surface/NN
receptor/NN
provides/VBZ
a/DT
major/JJ
costimulatory/JJ
signal/NN
for/IN
T/NN
cell/NN
activation/NN
resulting/VBG
in/IN
enhanced/VBN
production/NN
of/IN
interleukin-2/NN
(/(
IL-2/NN
)/)
and/CC
cell/NN
proliferation/NN
./.
=====
In/IN
primary/JJ
T/NN
lymphocytes/NNS
we/PRP
show/VBP
that/IN
CD28/NN
ligation/NN
leads/VBZ
to/TO
the/DT
rapid/JJ
intracellular/JJ
formation/NN
of/IN
reactive/JJ
oxygen/NN
intermediates/NNS
(/(
ROIs/NNS
)/)
which/WDT
are/VBP
required/VBN
for/IN
CD28-mediated/JJ
activation/NN
of/IN
the/DT
NF-kappa/NN
B/CD28-responsive/JJ
complex/NN
and/CC
IL-2/NN
expression/NN
./.
=====
Delineation/NN
of/IN
the/DT
CD28/NN
signaling/NN
cascade/NN
was/VBD
found/VBN
to/TO
involve/VB
protein/NN
tyrosine/NN
kinase/NN
activity/NN
,/,
followed/VBN
by/IN
the/DT
activation/NN
of/IN
phospholipase/NN
A2/NN
and/CC
5-lipoxygenase/NN
./.
=====
Our/PRP$
data/NNS
suggest/VBP
that/IN
lipoxygenase/NN
metabolites/NNS
activate/VBP
ROI/NN
formation/NN
which/WDT
then/RB
induce/VBP
IL-2/NN
expression/NN
via/IN
NF-kappa/NN
B/NN
activation/NN
./.
=====
These/DT
findings/NNS
should/MD
be/VB
useful/JJ
for/IN
therapeutic/JJ
strategies/NNS
and/CC
the/DT
development/NN
of/IN
immunosuppressants/NNS
targeting/VBG
the/DT
CD28/NN
costimulatory/NN
pathway/NN
./.